BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mas-Peiro S, Fichtlscherer S, Walther C, Vasa-Nicotera M. Current issues in transcatheter aortic valve replacement. J Thorac Dis 2020;12:1665-80. [PMID: 32395310 DOI: 10.21037/jtd.2020.01.10] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Kalogeropoulos AS, Redwood SR, Allen CJ, Hurrell H, Chehab O, Rajani R, Prendergast B, Patterson T. A 20-year journey in transcatheter aortic valve implantation: Evolution to current eminence. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.971762] [Reference Citation Analysis]
2 Mohr BA, Wadhwa M, Medic G, Lavelle J, Buchenberger JD, Norlock V. Costs and outcomes of mobile cardiac outpatient telemetry monitoring post-transcatheter aortic valve replacement. J Comp Eff Res 2022. [PMID: 35899700 DOI: 10.2217/cer-2022-0112] [Reference Citation Analysis]
3 Gallo F, Barolo A, Forlin E, Barbierato M. Transcatheter Treatment of Aortic Valve Disease Clinical and Technical Aspects. Cardiovascular Diseases [Working Title] 2022. [DOI: 10.5772/intechopen.105860] [Reference Citation Analysis]
4 Catalano C, Pasta S. On the Modeling of Transcatheter Therapies for the Aortic and Mitral Valves: A Review. Prosthesis 2022;4:102-12. [DOI: 10.3390/prosthesis4010011] [Reference Citation Analysis]
5 Kattih B, Carstens DC, Boeckling F, Rasper T, Pergola G, Dimmeler S, Vasa-Nicotera M, Zeiher AM, Mas-Peiro S. Low Circulating Musclin is Associated With Adverse Prognosis in Patients Undergoing Transcatheter Aortic Valve Implantation at Low-Intermediate Risk. J Am Heart Assoc 2022;:e022792. [PMID: 35229655 DOI: 10.1161/JAHA.121.022792] [Reference Citation Analysis]
6 Zisiopoulou M, Berkowitsch A, Neuber R, Gouveris H, Fichtlscherer S, Walther T, Vasa-nicotera M, Seppelt P. Personalized Preoperative Prediction of the Length of Hospital Stay after TAVI Using a Dedicated Decision Tree Algorithm. JPM 2022;12:346. [DOI: 10.3390/jpm12030346] [Reference Citation Analysis]
7 Anam SB, Kovarovic BJ, Ghosh RP, Bianchi M, Hamdan A, Haj-Ali R, Bluestein D. Assessment of Paravalvular Leak Severity and Thrombogenic Potential in Transcatheter Bicuspid Aortic Valve Replacements Using Patient-Specific Computational Modeling. J Cardiovasc Transl Res 2021. [PMID: 34859367 DOI: 10.1007/s12265-021-10191-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Figueroa-casanova R, Ramírez-sánchez JS, Pérez-rivera CJ, Arce-polania L, Acosta-buitrago LM. Reemplazo valvular aórtico transcatéter (TAVR) bajo oxigenación por membrana extracorpórea (ECMO) en estenosis aórtica: reporte de caso. Cirugía Cardiovascular 2021;28:113-6. [DOI: 10.1016/j.circv.2020.10.014] [Reference Citation Analysis]
9 Luraghi G, Rodriguez Matas JF, Migliavacca F. In silico approaches for transcatheter aortic valve replacement inspection. Expert Rev Cardiovasc Ther 2021;19:61-70. [PMID: 33201738 DOI: 10.1080/14779072.2021.1850265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Spears J, Al-Saiegh Y, Goldberg D, Manthey S, Goldberg S. TAVR: A Review of Current Practices and Considerations in Low-Risk Patients. J Interv Cardiol 2020;2020:2582938. [PMID: 33447165 DOI: 10.1155/2020/2582938] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
11 Mas-Peiro S, Seppelt PC, De Rosa R, Murray MI, Yogarajah J, Berkowitsch A, Fichtlscherer S, Zeiher AM, Vasa-Nicotera M. Potential Role and Prognostic Value of Erythropoietin Levels in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. Front Cardiovasc Med 2020;7:605257. [PMID: 33330669 DOI: 10.3389/fcvm.2020.605257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]